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Background: Chloride administration has been found to be harmful to the kidney in critically ill patients. However
the association between plasma chloride concentration and renal function has never been investigated.
Methods: This was a retrospective study conducted in a tertiary 24-bed intensive care unit from September 2010
to November 2012. Data on serum chloride for each patient during their ICU stay were abstracted from electronic
database. Cl0 referred to the initial chloride on ICU entry, Clmax, Clmin and Clmean referred to the maximum,
minimum and mean chloride values before the onset of AKI, respectively. AKI was defined according to the
conventional AKIN criteria. Univariate and multivariable analysis were performed to examine the association of
chloride and AKI development.
Results: A total of 1221 patients were included into analysis during study period. Three hundred and fifty-seven
patients (29.2%) developed AKI. Clmax was significantly higher in AKI than in non-AKI group (111.8 ± 8.1 vs
107.9 ±5.4 mmol/l; p < 0.001); Cl0 was not significantly different between AKI and non-AKI patients; Clmean was
significantly higher in AKI than non-AKI (104.3 ±5.8 vs 103.4 ± 4.5; p = 0.0047) patients. Clmax remained to be
associated with AKI in multivariable analysis (OR: 1.10, 95% CI: 1.08-1.13).
Conclusion: Chloride overload as represented by Clmean and Clmax is significantly associated with the development
of AKI.
Keywords: Acute kidney injury, Chloride, Intensive care unit, Critically illBackground
Acute kidney injury is a common complication of var-
ieties of critical illness and acts as a major contribution
to the high mortality rate in intensive care unit (ICU)
[1-3]. A large body of evidence suggests that even a mild
increase in serum creatinine will have significant nega-
tive impact on all-cause mortality [4,5]. Thus, great
effort has been made to elucidate the underlying mecha-
nisms of the development of AKI, based on which pre-
ventive or therapeutic strategies can be developed to
control this devastating complication. Although there
are numerous strategies for the prevention and treat-
ment of AKI including optimization of hemodynamic* Correspondence: zh_zhang1984@hotmail.com
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reproduction in any medium, provided the orstatus, use of vasodilators (e.g. dopamine and fenoldo-
pam), early initiation of continuous renal replacement
therapy and use of natriuretic peptides, most of them
failed to show a beneficial effect [6-10].
Critically ill patients receive large amount of intravenous
fluid administration during their ICU stay. Many commer-
cially available crystalloid fluids are rich in chloride; for
example, the most widely used saline 0.9% has 40% higher
chloride than human plasma. It is intuitive that the ad-
ministration of such non-physiological fluid will impair
the balance of internal homeostasis. Some animal studies
suggest that administration of chloride-liberal fluid in-
duces renal vasoconstriction and a decline in glomerular
filtration rate [11,12]. More recently, Yunos NM and col-
leagues [13] conducted a sequential period pilot study in
unselected critically ill patients and found that the inci-
dence of AKI can be reduced by 50% by using chloride-Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and the association between chloride and kidney function
remains to be elucidated. The present study aimed to in-
vestigate the association of plasma chloride and the devel-
opment of AKI in critically ill patients. We hypothesized
that plasma chloride was associated with the development
of AKI during ICU stay.
Methods
Study population and settings
This was a retrospective cohort study conducted in a ter-
tiary 24-bed mixed ICU from September 2010 through
November 2012. The hospital was a large academic
medical center with 2000 beds. All patients admitted to
the ICU during study period were potentially eligible for
the present analysis. All clinical data were abstracted
from Haitai e-chart (Haitai Medical information systems
Co.,LTD). Exclusion criteria were 1) patients with pre-
existing renal impairment as represented by a serum
creatinine > 135 μmol/l in the past 30 days before this
ICU admission; 2) patients with incomplete medical in-
formation that prohibit analysis; 3) patients transferred
to other hospitals before recovery; and such patients
were labeled as “automatically discharged” in e-chart; 4)
patients had no chloride measured during their ICU
stay; 5) patients younger than 18 years old. The study
was approved by the ethic committee of Jinhua munici-
pal central hospital and informed consent was waived
due to retrospective nature of the study.
Physiological scores for the severity of illness such as
acute physiology and chronic health evaluation (APACHE)
score and sequential organ failure assessment (SOFA)
score were not routinely obtained for each patients; thus,
we used the well validated Charlson’s comorbidity index
for risk adjustment [14,15]. Chloride was measured by au-
tomated chemistry analyzer (Sysmex, Sysmex Asia Pacific
Pte Ltd and Sysmex Corporation of Japan). The reference
range of chloride was 98 to 106 mmol/l. To explore the
temporal association of chloride values and AKI develop-
ment, only chloride values before the onset of AKI were
obtained from database. For patients without development
of AKI, all available chloride values during ICU stay were
obtained. Cl0 referred to the initial chloride on ICU entry,
Clmax, Clmin and Clmean referred to the maximum, mini-
mum and mean chloride values before the onset of AKI,
respectively. Because most critically ill patients had more
than one diagnosis, we used the primary diagnosis (the
one in the first sheet of medical chart) for the classifica-
tion of patients, as well as for subgroup analysis.
The primary outcome was the development of AKI as
defined by an increase in serum creatinine by >50% from
baseline [16]. If baseline creatinine was not available, it
was estimated by assuming that glomerular filtration rate
(GFR) in that given patient was 75 ml/min per 1.73 m2,and serum creatinine can be estimated by using the
modified 4-variable Modification of Diet in Renal Dis-
ease (MDRD) formula [17,18]. AKI patients were further
classified into AKIN-1,-2 and-3 according to acute kid-
ney injury network (AKIN) report [19]. Secondary out-
comes included hospital and ICU length of stay (LOS),
hospital mortality, use of continuous renal replacement
therapy (CRRT). If a patient had more than one episode
of ICU stay, ICU LOS was the sum of each.
Statistical analysis
Demographic and clinical data were compared between
AKI and non-AKI patients. Parametric data were expressed
using mean ± standard deviation (SD) and compared using
t test; non-parametric data were expressed as median and
interquartile range (IQR) and compared using Wilcoxon
rank-sum test. To determine the dose–response relation-
ship between chloride and AKI, chloride values were com-
pared among groups without AKI, with AKIN-1,-2 and-3
by using one-way analysis of variance (ANOVA). Multiple
comparisons were made by using Bonferroni method. Vari-
ables with p < 0.1 in bivariate analysis were incorporated
into Logistic regression model for risk adjustment. The
goodness-of-fit of the regression model was tested using
Homser-Lemeshow χ2 test. Sensitivity analysis was per-
formed by excluding patients with missing baseline cre-
atinine. All analyses were performed using the software
StataSE 11.2 (College Station, Texas 77845 USA). Con-
ventional two-tailed p < 0.05 was considered to be statis-
tically significant.
Results
A total of 1583 patients were identified during study
period. Three hundred and sixty-two of them were ex-
cluded because 352 had preexisting renal dysfunction
and 10 had incomplete medical information. As a result,
a total of 1221 patients were eligible for current analysis
(Table 1). Baseline serum creatinine levels were missing
in 203 patients. There were 357 patients (29.2%) devel-
oped AKI during their ICU stay. As compared with non-
AKI, patients with AKI were older (62.0 ± 19.8 vs 58.8 ±
19.5 years; p = 0.011), had higher Charlson comorbidity
index (1[0-2] vs 0[0-2]; p = 0.0095), more likely to use
mechanical ventilation (62.8% vs 43.3%, p < 0.001), and
had higher hospital mortality (27.2% vs 18.2%;p < 0.001),
longer hospital LOS (29 [20,41] vs 22 [15,33],p < 0.001),
and longer ICU LOS (4 [3,9] vs 3 [2,6]; p < 0.001). Pa-
tients in coronary care setting were less likely to develop
AKI (8% vs 14.4%; p = 0.002); and there was no differ-
ence in the incidence of AKI in medical, surgical and
post-cardiac surgery patients. AKI patients had more
fluid balance (1245 ± 782 vs 984 ± 780 ml; p < 0.001) and
greater amount of saline 0.9% infusion (1052 ± 768 vs
954 ± 650 ml; p = 0.023) than non-AKI patients. Cl0 was
Table 1 Baseline characteristics of included patients
Variables Total (n = 1221) AKI (n = 357) Non-AKI (n = 864) P value
Age (years) 59.7 ± 19.6 62.0 ± 19.8 58.8 ± 19.5 0.011
Sex (male, %) 788 (64.5%) 233 (65.3%) 556 (64.2%) 0.117
Charlson index (median, IQR) 0 (0-2) 1 (0-2) 0 (0-2) 0.0095
Primary Classification (n, %) <0.001
Medical 340 (27.8) 111 (31.1) 229 (26.5) 0.104
Coronary 152 (12.4) 28 (8.0) 124 (14.4) 0.002
Post-cardiac surgery 101 (8.0) 22 (6.0) 79 (9.0) 0.085
Surgical 628 (51.4) 196 (54.9) 432 (50.0) 0.119
Fluid balance (ml)† 1061 ± 789 1245 ± 782 984 ± 780 <0.001
Saline 0.9% administration (ml)† 983 ± 678 1052 ± 768 954 ± 650 0.023
Use of diuretics (n, %) 408 (33.42) 115 (32.21) 293 (33.91) 0.567
Use of MV (n; %) 598 (49.0) 224 (62.8) 374 (43.3) <0.001
Survivors (n; %) 967 (79.2) 260 (72.8) 707 (81.8) <0.001
Hospital LOS (days; median, IQR)‡ 24 (16,35) 29 (20,41) 22 (15,33) <0.001
ICU LOS (days; median, IQR) ‡ 3 (2,7) 4 (3,9) 3 (2,6) <0.001
Bicarbonate (mmol/l) 23.9 ± 3.0 24.0 ± 3.2 23.9 ± 2.9 0.46
Cl0 (mmol/l) 103.6 ±6.0 104.1 ± 7.3 103.4 ± 5.4 0.07
Clmean (mmol/l) 103.7 ±4.9 104.3 ±5.8 103.4 ± 4.5 0.0047
Clmin (mmol/l) 98.0 ± 5.8 97.2 ± 6.1 98.3 ± 5.6 0.002
Clmax (mmol/l) 109.1 ± 6.6 111.8 ± 8.1 107.9 ±5.4 <0.001
‡Analysis was restricted to survivors; † data obtained on the day of the onset of acute kidney injury or on the day of the highest serum creatinine level.
Abbreviations: AKI acute kidney injury, IQR interquartile range, MV mechanical ventilation, Cl0 chloride measured on ICU entry, Clmean mean chloride during ICU
stay, Clmin minimum chloride during ICU stay, Clmax maximum chloride during ICU stay.
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tients (104.1 ± 7.3 vs 103.4 ± 5.4 mmol/l; p = 0.07). Clmax
was significantly higher in AKI than in non-AKI patients
(111.8 ± 8.1 vs 107.9 ±5.4 mmol/l; p < 0.001), and Clmin
was significantly lower in AKI than in non-AKI (97.2 ±
6.1 vs 98.3 ± 5.6 mmol/l; p = 0.002). Clmean was signifi-
cantly higher in AKI than in non-AKI patients (104.3 ±5.8
vs 103.4 ± 4.5 mmol/l; p = 0.0047).
In multiple-comparison test, a dose–response relation-
ship was identified between Clmax and AKIN stages
(Table 2). AKIN-1 had significantly higher Clmax than
non-AKI (111.0 ± 7.4 vs 107.9 ± 5.4 mmol/l; p < 0.001),Table 2 Dose–response relationship between chloride
values and the severity of AKI
Non-AKI AKIN-1 AKIN-2 AKIN-3
Cl0 (mmol/l) 103.4 ± 5.4 103.4 ± 6.6 104.2 ± 6.6 106.7 ± 10.8
¶
Clmax (mmol/l) 107.9 ± 5.4 111.0 ± 7.4
¶ 111.7 ± 7.3¶ 115.9 ± 11.0 ¶
Clmin (mmol/l) 98.3 ± 5.6 97.3 ± 6.0 97.0 ± 5.2 96.7 ± 8.4
Clmean (mmol/l) 103.4 ± 4.5 103.8 ± 5.5 104.2 ± 5.1 106.7 ± 7.8
¶
Note: Differences among the four groups were tested using one-way analysis
of variance (ANOVA), and multiple comparisons were performed using
Bonferroni method.
¶Indicates the chloride value in the present AKI stage is significantly higher
than that in the milder stage in the left cell. For example, Clmax in AKIN-1 was
significantly higher than that in non-AKI (108.9 vs 107.8, p < 0.001).and AKIN-3 had significantly higher Clmax than AKIN-2
(115.9 ± 11.0 vs 111.7 ± 7.3; p < 0.05). Table 3 shows the
adjustment of odds ratio with multiple regression ana-
lysis. After adjustment, Clmax and Clmean remained to be
significantly associated the development of AKI with
odds ratio of 1.10 (95% CI: 1.08-1.13, p < 0.001) and 1.04
(95% CI: 1.02-1.07, p = 0.002), respectively. In patients
with AKI, a total of 45 patients required renal replace-
ment therapy. However, none of Clmin, Clmax or Clmean
was significantly different between AKI patients with
and without CRRT (data not shown).
Subgroup analysis was performed by restricting to pa-
tients with cardiovascular diseases, trauma, pancreatitis,Table 3 Logistic regression model to test independent
variables associated with AKI
Variables Odds ratio 95% confidence interval P
Cl0 1.02 0.998-1.05 0.06
Clmax 1.10 1.08-1.13 <0.001
Clmin 0.96 0.94-0.98 0.001
Clmean 1.04 1.02-1.07 0.002
Abbreviations: MV mechanical ventilation.
Note: the Logistic regression model was fitted by incorporating all potentially
confounding factors including bicarbonate level, use of diuretics, age, sex,
comorbidity score and primary diagnosis.
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CRRT. The results were generally consistent with the
overall analysis (Figure 1). Sensitivity analysis by exclud-
ing patients with missing baseline creatinine was per-
formed, and the results remained unchanged (data not
shown).
Discussion
Our study for the first time demonstrated that higher
Clmax and Clmean were associated with subsequent devel-
opment of AKI, while higher Clmin was protective
against the development of AKI. Furthermore, Clmax was
positively correlated to the severity of AKI as staged by
AKIN criteria.
Our result supports the notion that excessive chloride
intake has negative impact on renal function. In animal
study, Wilcox CS showed that chloride can induce vaso-
constriction and such effect is specific for the renal ves-
sels [11]. Other negative effects of chloride on kidney
include the reduction in cortical perfusion and the in-
crease in systemic inflammation. In a clinical trial, Wu
BU and colleagues [20] compared Ringer’s solution and
saline 0.9% on their effect on inflammatory response.
The result showed that patients who received saline
0.9% appeared to have higher C-reactive protein (CRP)
and systemic inflammatory response syndrome (SIRS)
levels. Since SIRS is a well known risk factor for AKI, it
is not surprising that elevated inflammatory level will
pose the kidney at increased risk of injury [21-23]. In an-
other study, Chowdhury AH and colleagues [24] found
that administration of saline 0.9% ([Cl] 154 mmol/L) sig-
nificantly reduced renal cortical tissue perfusion and
mean renal artery flow velocity as compared to the infu-
sion of Plasma-Lyte 148 ([Cl] 98 mmol/L). AlternativeFigure 1 Subgroup analysis restricting to patients with
cardiovascular diseases, trauma, pancreatitis, abdominal
problem, shock, without MV and without CRRT. OR, odds ratio;
MV, mechanical ventilation; CRRT, continuous renal
replacement therapy.explanation for the linkage between higher chloride and
AKI may be that these patients are more hypotensive
and require more saline. Another finding in our study is
that Clmin is protective against the development of AKI,
which can be explained by the fact that the optimal
serum chloride is within the normal range, and hypo-
chloremia has negative impact on renal function. How-
ever, there is no compelling evidence demonstrating the
negative impact of hypochloremia, and this mandates
further investigations. In a landmark study, Yunos NM
and coworkers [13] only reported that chloride-restrictive
arm received significantly less amount of chloride infusion
during study period (496 vs 694 mmol per patient), but
did not report serum chloride levels in both arms. This
limits the interpretation of the finding with respect to
whether use of chloride-restrictive fluid will benefit overall
population or just patients with hyperchloremia. Accord-
ing to our findings, we speculate that chloride-restrictive
strategy may not benefit patients with already existing
hypochloremia. Thus, it is of great interest to conduct a
randomized controlled trial by stratifying patients accord-
ing to their baseline serum chloride levels.
Several other studies show neutral effect of chloride-
restrictive strategy in protecting renal function [25-29].
However, these studies are performed in patients with
contrast-induced nephropathy (CIN). It is probable that
the protective effect of chloride-restrictive fluid is not
universal and can only be found in critically ill patients.
In CIN setting, the total amount of chloride infusion is
limited even in chloride-libel arm. In contrast, during
fluid resuscitation in ICU setting the amount of infused
fluid is much larger than that in CIN setting, allowing
the beneficial effect of chloride restriction large enough
to be detected.
In our study, we failed to identify an association be-
tween chloride and the use of renal replacement therapy
(RRT). This is in contrast to the study by Yunos NM
and coworkers in which chloride-restrictive strategy is
associated with reduced need for RRT. However, because
we excluded patients with preexisting renal impairment
on ICU entry, the number of patients requiring RRT is
extremely low in our study (4%). Such a small sample
size significantly limited the statistical power of our
study. Secondly, indications for the initiation of RRT
vary considerably across different areas and institutions,
and thus the comparison between our findings and re-
sults from other institutions should be cautious.
Many biomarkers in critical care medicine are found
to be predictive of clinical outcomes. For the prediction
of mortality, CRP, B-type natriuretic peptide and red cell
distribution width are found to be promising; [30,31]
and for the prediction of AKI, cystatin C and NGAL are
thought to be promising [32,33]. Such early identifica-
tion of adverse outcome may inform clinicians to adopt
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outcome. The clinical implication of our finding is that
while initial chloride value is not predictive of the AKI
development, the handling of chloride during treatment
is of vital importance. For a patient with hyperchloremia
on ICU entry, the use of chloride-restrictive strategy will
effectively reduce the risk of AKI. Conversely, if exces-
sive saline 0.9% is infused to a patient with normal
serum chloride level, he or she will be put on high risk
of AKI development. However, due to the observational
nature of our study; the result can only be served as
hypothesis-generating. Further well designed controlled
trials may help to solve this uncertainty [34].
There are several limitations in our study that should
be mentioned in interpretation of the results. First, the
measurement of serum chloride was not scheduled and
the obtained Clmax and Clmin might not reflect the true
values. Second, disease severity score such as SOFA or
APACHE ǁ was not incorporated into analysis, which
significantly limited the reliability of our result. However,
we used Charlson’s comorbidity index, which is access-
ible from administrative database, for risk stratification.
Although not as good as disease severity scores involving
physiologic parameters, Charlson’s index has been vali-
dated for use in critical care setting [14,15]. Third, al-
though we have tried our best to control bias and
confounders by using multivariate model, many other
known or unknown factors may still exist. Thus, the
conclusion of the study is at best hypothesis-generating,
and further experimental studies are mandatory to con-
firm current findings.
Conclusion
In aggregate, the study shows that higher Clmean and
Clmax are associated with the development of AKI,
indicating that chloride overload during ICU treatment
may increase the risk of AKI. Furthermore, higher Clmin
is found to be protective against AKI, indicating that
restricting chloride infusion is no longer beneficial in
patients with hypochloremia.
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